fbpx
April 4, 2022

First COVID-19 Human Challenge Study Provides Insights First COVID-19 Human Challenge Study Provides Insights

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A small droplet that contains the coronavirus can infect someone with COVID-19, […]
April 4, 2022

Doc Climbing Mt. Everest to Raise $1 Million for Cancer Research Doc Climbing Mt. Everest to Raise $1 Million for Cancer Research

The Mount Everest base camps, situated on either side of the world’s tallest mountain, are pitched at an altitude of about 17,500 feet ― a wise […]
April 4, 2022

Three Home-Based Visual Acuity Tests Validated Three Home-Based Visual Acuity Tests Validated

Three visual acuity tests taken at home produce results comparable to those achieved with standard tests taken in the office, researchers say. All the tests are […]
April 3, 2022

Mavacamten Controlled Hypertrophic Cardiomyopathy for >1 Year Mavacamten Controlled Hypertrophic Cardiomyopathy for >1 Year

WASHINGTON – Treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy who remained on treatment with the investigational agent mavacamten for a median of 62 weeks continued to […]
April 3, 2022

New HF Guidelines Feature ‘Quad’ Therapy, Tweaked Terminology New HF Guidelines Feature ‘Quad’ Therapy, Tweaked Terminology

The new heart failure (HF) guidelines released this week by three North American societies had a lot of catching up to do given the significant, even […]
April 3, 2022

APOLLO: SLN360 Clears First Major Hurdle, Hammering Lp(a) APOLLO: SLN360 Clears First Major Hurdle, Hammering Lp(a)

The short interfering RNA (siRNA) agent SLN360 was well tolerated and lowered lipoprotein(a) by up to 98% in volunteers without cardiovascular disease but with elevated Lp(a) […]
April 3, 2022

FAME 3 Subanalysis Adds Twist to Negative Primary Results FAME 3 Subanalysis Adds Twist to Negative Primary Results

A new subanalysis of the FAME 3 trial, which failed to show that percutaneous intervention (PCI) guided by fractional flow reserve (FFR) is noninferior to coronary […]
April 3, 2022

Supermarket Diet Advice Improves DASH Adherence: SuperWIN Supermarket Diet Advice Improves DASH Adherence: SuperWIN

People who received personalized nutrition education in a series of sessions at their regular grocery store significantly improved adherence to a healthy diet, in a new […]
April 3, 2022

Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA

In a randomized trial of patients with angina and no obstructive coronary artery disease (ANOCA), 6 weeks of treatment with diltiazem did not improve coronary vasomotor […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0